Evidence map›Paper›PMID 39587068›Full record

ArticleNature communications2024

Schwann cell C5aR1 co-opts inflammasome NLRP1 to sustain pain in a mouse model of endometriosis.

Mustafa Titiz, Lorenzo Landini, Daniel Souza Monteiro de Araujo, Matilde Marini, Viola Seravalli, Martina Chieca, Pasquale Pensieri, Marco Montini, Gaetano De Siena, Benedetta Pasquini and 13 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Dual role of complement in neuronal repair.Frontiers in immunology · 2025
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Mustafa Titiz *Department of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.ORCID 0000-0003-1278-6744
Lorenzo Landini *Department of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.ORCID 0000-0002-3933-2497
Daniel Souza Monteiro de Araujo *Department of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.ORCID 0000-0003-1115-725X
Matilde MariniDepartment of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.ORCID 0000-0002-2199-2905
Viola SeravalliDepartment of Health Science, Obstetrics and Gynecology Section, University of Florence, Florence, Italy.
Martina ChiecaDepartment of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.ORCID 0000-0002-0247-9938
Pasquale PensieriDepartment of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.
Marco MontiniDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", Medical Genetics Unit, University of Florence, Florence, Italy.
Gaetano De SienaDepartment of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.
Benedetta PasquiniDepartment of Chemistry "U.Schiff", University of Florence, Florence, Italy.
Silvia VannucciniDepartment of Experimental and Clinical Biomedical Sciences, Obstetrics and Gynecology Unit, University of Florence, Florence, Italy.
Luigi Francesco IannoneDepartment of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.
Thiago M CunhaCenter for Research in Inflammatory Diseases (CRID), Department of Pharmacology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-1084-0065
Giulia BrancoliniFloNext srl, Florence, 50123, Italy.ORCID 0009-0008-9269-8253
Elisa BellantoniDepartment of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.
Irene ScuffiDepartment of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.
Alessandra MastricciDepartment of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.ORCID 0009-0009-3755-8802
Martina TesiDepartment of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.ORCID 0009-0004-2352-4277
Mariarosaria Di TommasoDepartment of Health Science, Obstetrics and Gynecology Section, University of Florence, Florence, Italy.
Felice PetragliaDepartment of Experimental and Clinical Biomedical Sciences, Obstetrics and Gynecology Unit, University of Florence, Florence, Italy.
Pierangelo GeppettiDepartment of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy.ORCID 0000-0003-3797-8371
Romina NassiniDepartment of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy. romina.nassini@unifi.it.ORCID 0000-0002-9223-8395
Francesco De LoguDepartment of Health Science, Clinical Pharmacology and Oncology Section, University of Florence, Florence, Italy. francesco.delogu@unifi.it.ORCID 0000-0001-8360-6929

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 835286Fondazione Telethon (Telethon Foundation) GMR22T1070Ministero della Salute (Ministry of Health, Italy) GR-2018-12368352 (Bando Salute 2018)
6 · The paper itself

Abstract

Over 60% of women with endometriosis experience abdominopelvic pain and broader pain manifestations, including chronic back pain, fibromyalgia, chronic fatigue, vulvodynia, and migraine. Although the imbalance of proinflammatory mediators, including the complement component C5a, is associated with endometriosis-related pain, the mechanisms causing widespread pain and the C5a role remain unclear. Female mice and women with endometriosis exhibit increased plasma C5a levels and pain. We hypothesize the Schwann cells involvement in endometriotic pain. Here, we show that silencing the C5a receptor (C5aR1) in Schwann cells blocks the C5a-induced activation of the NLRP1 inflammasome and subsequent release of interleukin-1β (IL-1β). Macrophages, recruited to sciatic/trigeminal nerves by IL-1β from Schwann cells, increase oxidative stress, which activates the proalgesic TRPA1 pathway, resulting in widespread pain. These findings reveal a pathway involving Schwann cell C5aR1, NLRP1/IL-1β activation, macrophage recruitment, oxidative stress, and TRPA1 engagement, contributing to pain in a mouse model of endometriosis.

Indexed as

Disease Models, AnimalEndometriosisInflammasomesInterleukin-1betaMacrophagesReceptor, Anaphylatoxin C5aSchwann CellsTRPA1 Cation ChannelAdaptor Proteins, Signal TransducingAnimalsApoptosis Regulatory ProteinsComplement C5aFemaleHumansMiceMice, Inbred C57BLAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsC5ar1 protein, mouseComplement C5aInflammasomesInterleukin-1betaNALP1 protein, mouseReceptor, Anaphylatoxin C5aTRPA1 Cation ChannelTrpa1 protein, mouse

Identifiers

PMID39587068
PMCPMC11589863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.